Gabapentin

Product NDC: 50090-1681
11-digit product format: 500901681
Labeler code: 50090
Product ID: 50090-1681_4407f4c6-dc9e-42d9-86da-9a7bc54c1ad1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Gabapentin
Dosage form: CAPSULE
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA075360
Marketing category: ANDA
Marketing start: 2005-04-06
Marketing end: 0000-00-00
Substance: GABAPENTIN
Active strength: 400 mg/1
Pharmacologic classes: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-1681-0	2020-02-14	C162847	48780-1	9d75b9d0-5239-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
50090-1681-0	2020-01-31	C162847	48780-1	9d75b9d0-5239-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993